Presentation on theme: "CAN WE PREVENT NECROTIZING ENTEROCOLITIS (NEC)?"— Presentation transcript:
1 CAN WE PREVENT NECROTIZING ENTEROCOLITIS (NEC)? Reese H Clark, MDVice-President and Co-DirectorThe Center for Research, Education, and QualityPediatrix Medical Group
2 OBJECTIVES To define the term NEC Review the evidence that NEC can be reduced.Discuss implementation of specific approaches to reduce NEC
3 WHAT IS NEC?It is a window of developmental vulnerability in which innate immunity can be over-activated and the resulting inflammation triggers necrotic obliteration of the neonatal intestinal mucosaIt occurs at a stereotypic time in relation to the gestation at birth (the younger the gestation the later the onset)It requires that the infant be fed (substantially)It almost never occurs when the intestinal immune system is mature and intact, even if other risk factors are presentThe triggering of NEC is a multi-factorial phenomena, much like BPD, many risk factors heighten neonatal intestinal inflammation until an irreversible “waterline” is surpassed and mucosal necrosis proceeds.
4 DIFFERENTIAL DIAGNOSIS OF NEC Spontaneous ileal perforationIntestinal volvulusSepsis with ileusTerm infant: consider invasive enteritis (viral, salmonella/yersinia/c.diff/E. coli 0157)Late onset consider allergic colitis
5 PROPOSED DEFINITION FOR NEC PHILL GORDON Acute abdominal distention from focal or global ileus while on > 40 ml/kg/day of enteral feedsANDRadiographic pneumatosis on day of diagnosisOR persistent platelet consumption > 4 days from day of diagnosisOR portal air on the day of diagnosis (not to include iatrogenic)OR surgical / autopsy confirmation of > 4 cm of necrotic bowel with pneumatosis that extends beyond the immediate margins of a solitary perforation. Focal gangrene that principally affects the serosa surrounding a solitary perforation should not be labelled “NEC”.Things that should NOT be used as diagnostic criteria for NECPneumoperitoneum – confounded by SIP / congenital sources of perforationBloody stools – confounded by cows milk intolerance / colitis / iron supplements
6 In about one-third of cases, NEC is suspected but not confirmed (stage I), and symptoms resolve gradually in these infants.In 25 to 40 percent of cases, the progression of NEC is fulminant with signs of peritonitis and sepsis, and the rapid development of DIC and shock (stage III).
7 Spontaneous Intestinal Perforations Is unrelated to feedsIs always a surgical disease (and thus is a common surgical NEC contaminant)Occurs at an earlier time of life than NECAffects a younger gestational populationHas unique risk factors (early postnatal steroids and NSAIDs) which are not associated with NECHas different histology/pathology from NEC
10 SPONTANEOUS INTESTINAL PERFORATION (SIP) Typically found at the terminal ileum.Occurs primarily in premature, very low birth weight (VLBW, birth weight <1000 g) infantsSIP generally presents within the first 10 days of life as an acute onset of abdominal distension and hypotension. The classical physical finding is a black-bluish discoloration of the abdominal wall. In contrast, abdominal wall erythema, crepitus, and induration commonly seen with NEC are not usually present in infants with SIP.Long-term survival of infants with SIP has improved over the past 30 years with reported survival rates of 64 to 90 percent. However, survivors are at risk for neurodevelopmental impairment.
14 SYMPTOMS (MAY COME ON SLOWLY OR SUDDENLY) Abdominal distentionApnea and bradycardiaBlood in the stoolDiarrheaFeeding intoleranceLethargyTemperature instabilityVomiting
15 PROPOSED DEFINITION FOR NEC PHIL GORDON Acute abdominal distention from focal or global ileus while on > 40 ml/kg/day of enteral feedsANDRadiographic pneumatosis on day of diagnosisOR persistent platelet consumption > 4 days from day of diagnosisOR portal air on the day of diagnosis (not to include iatrogenic)OR surgical / autopsy confirmation of > 4 cm of necrotic bowel with pneumatosis that extends beyond the immediate margins of a solitary perforation. Focal gangrene that principally affects the serosa surrounding a solitary perforation should not be labelled “NEC”.Things that should NOT be used as diagnostic criteria for NECPneumoperitoneum – confounded by SIP / congenital sources of perforationBloody stools – confounded by cows milk intolerance / colitis / iron supplements
19 RISK FACTORS ASSOCIATED WITH DEATH FROM NEC Lower estimated gestational ageLower birth weightTreatment with assisted ventilation on the day of diagnosis of NECTreatment with vasopressors at the time of diagnosisBlack racePatients who received only ampicillin and gentamicin on the day of diagnosis were less likely to die.
20 RISK FACTORS ASSOCIATED WITH RAPID DEATH FROM NEC Two-thirds of NEC deaths occurred quickly (<7 days from diagnosis), with a median time of death of one day from time of diagnosis.Infants who died within 7 days of diagnosis had a higher birth weight, more often were on vasopressors and high frequency ventilation at the time of diagnosis compared with patients who died at 7 or more days.
21 Clark RH, Gordon P, Walker WM, Laughon M, Smith PB, Spitzer AR Clark RH, Gordon P, Walker WM, Laughon M, Smith PB, Spitzer AR. Characteristics of patients who die of necrotizing enterocolitis. J Perinatol. 2012;32:
23 Necrotizing enterocolitis: current perspectives Phani Kiran Yajamanyam, Shree Vishna Rasiah, and Andrew K Ewer
24 IMPORTANT INTERVENTIONS THAT REDUCE THE RISK OF NEC Human milk (both mother’s & donor milk programs)Standardized feeding guidelines (including early initiation)ProbioticsAntibiotic stewardshipOptimization of enteral nutrition and growthElimination of H2 blockers and acid pump suppressorsElimination of cows milk productsTransfusion protocols and transfusion outcome monitoring
26 Adjusted survival curves for necrotizing enterocolitis (NEC) or death by proportion of human milk to total intake over the first 14 days of life. Survival curves adjusted for birth weight, small for gestational age, race, patent ductus arteriosus (PDA), antenatal steroids, duration of mechanical ventilation and Network Center. The numbers on the graph (0, 0.25, 0.50, 0.75 and 1.0) represent the proportion of total intake that is human milk. Survival curves represent predicted survival time free of NEC or death and do not directly correspond to the number of infants.Meinzen-Derr J, et. al. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol January ; 29(1): 57–62. RR = 0.83 (CI 0.72, 0.96) for each 10% increase in the proportion of total intake as HM.
27 Quigley M, McGuire W. Formula milk versus donor breast milk for feeding preterm or low birth weight infants Updated. Published Online: 22 April 2014Nine trials, in which 1070 infants participated, fulfilled the inclusion criteria. Four trials compared standard term formula versus donor breast milk and five compared nutrient-enriched preterm formula versus donor breast milk.Only the two most recent trials used nutrient-fortified donor breast milk. The trials contain various methodological quality weaknesses, specifically uncertainty about adequate allocation concealment methods in three trials and lack of blinding in most of the trials.Formula-fed infants had higher in hospital rates of increase in weight [mean difference (MD): 2.58 (95% confidence interval (CI) 1.98 to 3.71) g/kg/day], length [MD 1.93 (95% CI 1.23 to 2.62) mm/week] and head circumference [MD 1.59 (95% CI 0.95 to 2.24) mm/week].No effect on post-discharge growth rates or neurodevelopmental outcomes.Formula feeding increased the risk of necrotizing enterocolitis: typical risk ratio 2.77 (95% CI 1.40 to 5.46); risk difference 4% (95% CI 2% to 7%).
28 For every 10 mL/kg per day increase in breast milk Vohr BR, et al. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics 2007;120(4):e953-e959.For every 10 mL/kg per day increase in breast milkMental Developmental Index increased by 0.59 points,Psychomotor Developmental Index by 0.56 points,Behavior percentile score by 0.99 pointsRisk of rehospitalization between discharge and 30 months decreased by 5%.
30 Superhero sugars in breast milk make the newborn gut safe for beneficial bacteria by Jessica Shugart 2:05pm, December 27, 2013 https://www.sciencenews.org/article/mother-lode
31 Superhero sugars in breast milk make the newborn gut safe for beneficial bacteria by Jessica Shugart 2:05pm, December 27, 2013 https://www.sciencenews.org/article/mother-lode
32 COLOSTRUM FEEDINGSColostrum is a pre-milk fluid rich in immunoglobulins and immune cells that is produced during the first hours postpartum.It is very like a medicine and may play an important role in protecting preterm infants
34 Cristofalo EA, Schanler RJ, Blanco CL, Sullivan S, Trawoeger R, Kiechl-Kohlendorfer U, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163:A multicenter randomized trial in extremely preterm infants compared a feeding regimen based exclusively on human milk (donor breast milk with fortifier derived from human milk) to one using preterm formula and fortifier derived from cow’s milkInfants were eligible if their mothers did not provide their own breast milkInfants fed with the human milk regimen had a shorter duration of parenteral nutrition and a lower rate of surgical NEC, but the rate of NEC overall was not statistically different in the two groups.The incidence of NEC in the group fed formula was very high (21%), much higher than the usual rate of NEC
35 Cristofalo EA, Schanler RJ, Blanco CL, Sullivan S, Trawoeger R, Kiechl-Kohlendorfer U, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163:
36 Human Breast Milk- Donor Meta-analysis showed risk of NEC increased by 2.5 if fed formula vs. DBMThis was donor BM (pasturized- not all enzymes), not MBMIncreased risk with formulaOld studiesDonor BM likely has protective effect against NEC as wellQuigley, et al. Cochrane 200836
37 Hair AB, Hawthorne KM, Chetta KE, Abrams SA Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants </= 1250 grams birth weight. BMC Res Notes. 2013;6:459.Single center, prospective observational cohort study, preterm infants weighing ≤ 1250 g BW were fed an exclusive human milk-based diet until 34 wks postmenstrual ageEvaluated 104 infants with mean EGA of 27.6 ± 2.0 wks and BW of 913 ± 181 gmHuman milk fortification with donor human milk derived fortifier was started at 60 mL/kg/d and advanced to provide 6 to 8 additional kilocalories per ounceWeight gain was 24.8 ± 5.4 g/kg/day with length 0.99 ± 0.23 cm/week and head circumference 0.72 ± 0.14 cm/week.Weight velocity was affected by day of fortification and day of full feeds
40 Morgan J, Young L, McGuire W Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotizing enterocolitis in very low birth weight infants. Cochrane Database Syst Rev Mar 28;3:CDFive randomized controlled trials in which a total of 588 infants participated.Few participants were extremely preterm, extremely low birth weight or growth restricted.The trials defined slow advancement as daily increments of 15 to 20 ml/kg and faster advancement as 30 to 35 ml/kg.Meta-analyses did not detect statistically significant effects on the risk of necrotizing enterocolitis (typical risk ratio (RR) 0.97, 95% confidence interval (CI) 0.54 to 1.74) or all-cause mortality (RR 1.41, 95% CI 0.81 to 2.74).Infants who had slow advancement took significantly longer to regain birth weight (reported median differences two to six days) and to establish full enteral feeding (two to five days).
41 Morgan J, Young L, McGuire W Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotizing enterocolitis in very low birth weight infants. Cochrane Database Syst Rev Mar 28;3:CD
42 Clyman R, et al. Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus. J Pediatr. 2013;163:23(1/7)-30(6/7) weeks' gestationweighed g at birth,received maximum enteral volumes </=60 mL/kg/d,and were about to be treated with indomethacin or ibuprofen.Randomized at 6.5 +/- 3.9 days to receive "trophic" feeds ("feeding" group, n = 81: indomethacin 80%, ibuprofen 20%) or no feeds ("fasting/NPO" group, n = 96: indomethacin 75%, ibuprofen 25%) during the drug administration period.Infants randomized to the "feeding" arm required fewer days to reach the study's feeding volume end point (120 mL/kg/d).Although the enteral feeding end point was reached at an earlier postnatal age, the age at which central venous lines were removed did not differ between the 2 groups.There were no differences between the 2 groups in the incidence of infection, necrotizing enterocolitis, spontaneous intestinal perforation, or other neonatal morbidities.
43 ACID REDUCING AGENTS DO NOT WORK AND MAY BE DANGEROUS
44 Efficacy and Safety of Once-Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease in Neonatal Patients. Journal of Pediatrics DOI: /j.jpedsThere were no significant differences between the esomeprazole and placebo groups in the percentage change from baseline in the total number of GERD-related signs and symptoms (-14.7% vs -14.1%, respectively).Mean change from baseline in total number of reflux episodes was not significantly different between esomeprazole and placebo (-7.43 vs -0.2, respectively); however, the percentage of time pH was <4.0 and the number of acidic reflux episodes >5 minutes in duration was significantly decreased with esomeprazole vs placebo (-10.7 vs 2.2 and -5.5 vs 1.0, respectively; P ≤ .0017).
45 Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. 34/91 (37%) vs 18/183 (10%) OR=5.5 [2.9, 10.4]9.8 vs 1.6%OR=6.6 [ ]9.9 vs 1.6%OR=6.6 [ ]Terrin G, et al. Pediatrics 2012;129(1):e40-e45
46 Terrin G, et al. Pediatrics 2012;129(1):e40-e45
47 Gupta RW, Tran L, Norori J, Ferris MJ, Eren AM, Taylor CM, et al Gupta RW, Tran L, Norori J, Ferris MJ, Eren AM, Taylor CM, et al. Histamine-2 receptor blockers alter the fecal microbiota in premature infants. J Pediatr Gastroenterol Nutr 2013 Apr;56(4):The objective of the present study was to test the hypothesis that histamine-2 receptor (H2-) blockers alter colonic bacterial colonization by analyzing and comparing the fecal microbiota in premature infants with and without H2-blocker therapy using sensitive molecular biological techniques.Seventy-six premature infants </=1500 g or <34 weeks gestation were enrolled in this case-controlled, cross-sectional study. Stool samples were collected from 25 infants receiving H2-blockers and 51 babies who had never received them.Proteobacteria and Firmicutes were the major phyla contributing to fecal microbial communities.Microbial diversity was lower, relative abundance of Proteobacteria (primarily of the family Enterobacteriaceae) was increased, whereas that of Firmicutes was decreased in the stools of infants receiving H2-blockers compared with those who had never received them.
49 Prolonged Antibiotic Therapy for "Culture-Negative" Sepsis in Preterm Infants: It's Time to Stop! Prolonged antibiotic therapy is more related to institutional decisions than severity of illnessBiological plausibility to explain some of these negative associations.Antibiotic therapy affects gastrointestinal flora of preterm infants which can impact the development of NEC and late-onset sepsis, both of which can lead to death.Elimination of commensal flora allows for colonization by multi-drug resistant organisms and fungiCantey JB. J Pediatr. 2011;159:
50 Association Of Initial Empirical Antibiotic Treatment With Necrotizing Enterocolitis And Death For Extremely Low Birth Weight InfantsRetrospective cohort analysis of ELBW infants admittedDefined initial empirical antibiotic treatment duration as continuous days of antibiotic therapy started in the first 3 postnatal days with sterile culture results.Prolonged empirical antibiotic therapy (≥5 days)4039 infants survived >5 days and included in studyMedian therapy duration was 5 days (range: 1-36 days);2147 infants (53%) received prolonged empirical therapy (center range: 27%-85%).Multivariable analyses (adjusted for GA, Apgar score, race, center) prolonged therapy was associated with increased odds of necrotizing enterocolitis or death and death alone.Cotten, Pediatrics, 2009.
51 Antimicrobial Exposure and NEC Yale cohort replicates association reported by Cotten Alexander. J Pediatr. 2011;159(3):392-7.
53 Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics Dec;132(6):A prospective multicenter, double-blinded, placebo-controlled, randomized trial compared daily administration of a probiotic combination (Bifidobacterium infantis, Streptococcus thermophilus, and Bifidobacterium lactis, containing 1 × 10(9) total organisms) with placebo (maltodextrin) in infants born before 32 completed weeks' gestation weighing <1500 g.The primary outcome was at least 1 episode of definite late-onset sepsis.October 2007 and November 20111099 very preterm infants from Australia and New Zealand were randomized.Rates of definite late-onset sepsis (16.2%), NEC of Bell stage 2 or more (4.4%), and mortality (5.1%) were low in controls, with high breast milk feeding rates (96.9%).No significant difference in definite late-onset sepsis or all-cause mortality was foundProbiotic combination reduced NEC of Bell stage 2 or more (2.0% versus 4.4%; relative risk 0.46, 95% confidence interval 0.23 to 0.93, P = .03; number needed to treat 43, 95% confidence interval 23 to 333).
54 Length of stay was 3-4 days shorter. William Tarnow-Mordi and Roger Soll. Probiotic Supplementation in Preterm Infants: It Is Time to Change Practice. The Journal of Pediatrics Volume 164, Issue 5 , Pages , May 2014.Probiotic supplementation in preterm infants is perhaps the best studied yet least used therapy in neonatal medicine.All recently published meta-analyses have reported significant impacts on important clinical outcomes.In the updated Cochrane meta-analysis, which includes 24 trials, there is a significant decrease in necrotizing enterocolitis (NEC) (relative risk 0.43, 95% CI ; risk difference of 3%; and all-cause mortality (RR 0.65, 95% CI ).Length of stay was 3-4 days shorter.There was no probiotic-related sepsis, although this is rarely reported outside trials.Probiotics are still infrequently used in North America. In 2012, only 8%-9% of very low birth weight (VLBW) infants in the Vermont Oxford Network received probiotics.
55 FEASIBILITYHow do we know that we can actually impact NEC on a national level?Because we already have…
56 100,000 babies Campaign… (credit to Dan Ellsbury & Robert Ursprung) Enhance Nutrition:Maximize breast milk use, use a standardized feeding protocol, and provide early proteinImprove Medication Use:Optimize use of antenatal steroids, caffeine, and surfactant. Optimize antibiotic choice and exposure, decrease cephalosporin use, H-2 blocker use, and postnatal steroid use, standardize oxygen managementOptimize Central Line Use:Standardized central line insertion process, standardized central line maintenance process, and minimize central line durationReduce Suboptimal Admission Temperatures:Standardize initial thermal management
57 GI Medications Use Rates (Per 1000 Patients Based Counted Only Once Per Patient) Source: Pediatrix Clinical Data Warehouse
60 Since 100,000 babies…g inborn only, high volume units only
61 Change in Reports of Medical or Surgical NEC in PDX or VON (Inborn, 401-1500 grams = VLBW All)
62 Site Variability in NEC Observed Rate 5 year period, Inborn, VLBW
63 More than 0 Extra Cases Less than 0 fewer Cases 5 year period, Inborn, VLBW Case Avoided
64 Vaidyanathan Ganapathy et al Vaidyanathan Ganapathy et al. Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: a retrospective longitudinal study among infants enrolled in Texas Medicaid. BMC Pediatrics 2013, 13:127Two hundred fifty NEC survivors (73 with surgical NEC) and 2,909 matched controls were available for follow-up.Medical NEC infants incurred significantly higher healthcare costs than matched controls between 6–12 months of age (mean incremental cost = US$ 5,112 per infant).No significant difference in healthcare costs between medical NEC infants and matched controls was seen after 12 months.Surgical NEC survivors incurred healthcare costs that were consistently higher than that of matched controls through 36 months of age.The mean incremental healthcare costs of surgical NEC infants compared to matched controls between 6–12, 12–24 and 24–36 months of age were US$ 18,274, 14,067 (p < 0.01) and 8,501 (p = 0.06) per infant per six month period, respectively.